JESSICA SHEEHAN: Open Payments
NPI 1467654772 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 19 payments from 12 companies in 2025. Trend: 2023 $432 · 2024 $1,115 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $61 |
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Tris Pharma Inc | 1 | $15 |
Products named: Ozempic, MOUNJARO, NEXLETOL, OTEZLA, VRAYLAR, GEMTESA, PREVNAR 20, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
